This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Why Is Atrial Fibrillation Undertreated in Patients With CABG and Structural Disease?
Ad N, Gerdisch MW, Chikwe J, Thourani VH. Why is Atrial Fibrillation Undertreated in Patients With CABG and Structural Disease?. September 2020. doi:10.25373/ctsnet.12931028
Filmed at the 2020 STS Annual Meeting in New Orleans, Louisiana, Niv Ad of the Washington Adventist Hospital and University of Maryland moderates a discussion on the importance of atrial fibrillation in decision-making in structural heart disease and coronary artery disease. He is joined by Marc Gerdisch of the Franciscan St. Francis Heart Center in Indianapolis, Indiana, USA; Joanna Chikwe of Cedars Sinai Medical Center in Los Angeles, California, USA; and Vinod Thourani of the Piedmont Heart Institute in Atlanta, Georgia, USA.
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.